Trump Administration's $500 Million Gamble on Outdated Flu Vaccine Tech Raises Eyebrows Among Scientists
The Trump administration's surprise decision to invest $500 million in a universal flu vaccine has left the scientific community perplexed. Despite the urgent need for a broadly protective flu shot, experts are questioning the choice of technology, which is considered outdated. With the project still in its infancy, many are wondering if this massive investment will yield the desired results. As the world grapples with pandemic preparedness, the focus on old vaccine technology has sparked debate about the best approach to combating infectious diseases. With the rise of modern vaccine technologies, such as mRNA and viral vector-based vaccines, some experts are calling for a more innovative approach. The use of outdated technology may hinder the development of effective flu vaccines, highlighting the need for a more forward-thinking strategy in pandemic preparedness and vaccine development, including the use of artificial intelligence and machine learning in vaccine research.